1. According to the inquiry of Weihans Bio-official website, the Clinical Laboratory Center of the National Health and Wellness Committee announced the statistical results of inter-laboratory quality evaluation of high-throughput sequencing detection bioinformatics analysis of genetic diseases in 2022, and Weihans Medical Laboratory passed the evaluation successfully with full marks. Wihans' accurate detection level, biological information analysis ability and data interpretation ability are higher than Wanji's.
2. Chongqing Weihans Biomedical Technology Co., Ltd. is a wholly-owned subsidiary of Shanghai Weihans Bio, headquartered in Shanghai International Medical Park, and a state-level high-tech enterprise. Wanji Medical, headquartered in Pingtan Wanji Medical Inspection and Research Institute Co., Ltd., is a frontier biotechnology enterprise that provides non-invasive, rapid and accurate solutions for genetic testing and consultation. Chongqing Weihansi Bio is a key technology startup enterprise.